Earnings News - Candlesense

VolitionRx Limited Announces Second Quarter 2025 Financial Results and Business Update

Conference call to discuss financial and operational results scheduled for Friday, August 15 at 8:30 a.m. U.S. Eastern Time HENDERSON, Nev., Aug. 14, 2025 /PRNewswire/ -- VolitionRx Limited (NYSE A...

What macro‑economic or sector trends could influence VolitionRx's performance in the coming quarters? How does the company's valuation metrics (e.g., P/E, EV/EBITDA) compare to its competitors after this earnings update? Did the management address any regulatory or reimbursement risks that could impact future performance?

Symbol: VNRX

26 days ago

Venu Holding Corporation Reports Second Quarter 2025 Financial Results

COLORADO SPRINGS, Colo.--(BUSINESS WIRE)---- $VENU #Earningsreport--Venu Holding Corporation ("VENU" or the “Company”) (NYSE American: VENU), a developer, owner, and operator of upscale live music ...

How does VENU's performance compare to its direct competitors (e.g., Live Nation, AEG, regional venue operators)? What is the analyst consensus rating and target price for VENU, and how might the latest results affect those expectations? How does the company's shareholder return strategy (dividends, share repurchases) evolve in light of the quarterly results?

Symbol: VENU

26 days ago

BioStem Technologies Reports Preliminary Second Quarter 2025 Financial Results

How might the preliminary nature of the results influence analyst coverage and upcoming research reports? Are there any risks or uncertainties highlighted in the release that could affect the stock's upside potential? What is the market's reaction to the preliminary results, and are there any abnormal trading volumes or price movements?

Symbol: BSTI

26 days ago

Read more globenewswire

Docusign Announces Timing of Second Quarter Fiscal 2026 Earnings Conference Call

SAN FRANCISCO, Aug. 14, 2025 /PRNewswire/ -- Docusign (Nasdaq: DOCU) today announced that its second quarter fiscal 2026 results will be released on Thursday, September 4, 2025, after the close of ...

What is the expected impact of the earnings release on DOCU's stock liquidity and order flow, and how should I position my trades around the call? Will the company address any recent regulatory developments or competitive pressures that could affect its growth trajectory? How might macro‑economic factors (e.g., interest rates, corporate spending trends) influence DOCU's performance and the market's reaction to the earnings release?

Symbol: DOCU

26 days ago

Shimmick Corporation Announces Second Quarter 2025 Results

IRVINE, Ca., Aug. 14, 2025 (GLOBE NEWSWIRE) -- Shimmick Corp. (NASDAQ: SHIM), a leading infrastructure solutions provider in water, climate resilience, energy transition and sustainable transport...

Does the earnings call transcript reveal any changes in management strategy or execution priorities that could impact the stock? What potential risks or uncertainties (e.g., project delays, supply chain constraints) were highlighted in the management commentary? Are there any regulatory or policy developments (e.g., infrastructure funding, ESG incentives) mentioned that could affect the company's growth trajectory?

Symbol: SHIM

26 days ago

Read more globenewswire

Profound Medical Announces Second Quarter 2025 Financial Results

TORONTO, Aug. 14, 2025 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets customi...

What are the potential risks or headwinds highlighted in the MD&A that could affect future performance? Did the company disclose any significant contract wins, partnerships, or supply‑chain updates that could affect future revenue? What is the impact of foreign‑exchange fluctuations and other non‑recurring items on the results?

Symbol: PROF

26 days ago

Read more globenewswire

Bolt Biotherapeutics Reports Second Quarter 2025 Financial Results and Provides Business Update

REDWOOD CITY, Calif., Aug. 14, 2025 (GLOBE NEWSWIRE) -- Bolt Biotherapeutics (Nasdaq: BOLT), a clinical-stage biopharmaceutical company developing novel immunotherapies for the treatment of cance...

What is the current shareholder composition and are there any upcoming lock‑up expirations or insider sales that could affect share supply? How will the expansion of the BDC-4182 trial to other countries affect cash burn and operational risk? What are the potential regulatory hurdles for the next‑generation Boltbody™ ISAC platform, and how might they affect timeline and valuation?

Symbol: BOLT

26 days ago

Read more globenewswire

Venus Concept Announces Second Quarter 2025 Financial Results

TORONTO, Aug. 14, 2025 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, announced financial results for the ...

What risk factors (e.g., regulatory, supply chain, litigation) were highlighted in the filing, and how might they affect the stock’s risk profile? Are there any notable changes in the competitive landscape (e.g., competitor earnings, market share shifts) that could impact Venus Concept’s market position? How does the company's valuation (P/E, EV/EBITDA, price/earnings growth) compare to other medical aesthetic technology companies?

Symbol: VERO

26 days ago

Read more globenewswire

authID Reports Financial and Operating Results for the Second Quarter 2025; Delivers the Highest Revenue in the Company’s History

DENVER, Aug. 14, 2025 (GLOBE NEWSWIRE) -- authID® (Nasdaq: AUID) (“authID” or the “Company”), a leading provider of biometric identity verification and authentication solutions, today reported fi...

Are there any risks or uncertainties highlighted in the MD&A that could impact the stock's volatility? Does the company provide any updates on its customer pipeline, contract wins, or partnership developments that could drive future revenue? What regulatory or macroeconomic factors could influence the company's performance moving forward?

Symbol: AUID

26 days ago

Read more globenewswire

TOMI Environmental Solutions, Inc. Reports Q2 2025 Financial Results and Outlines Growth Initiatives

FREDERICK, Md., Aug. 14, 2025 (GLOBE NEWSWIRE) -- TOMI Environmental Solutions, Inc. (NASDAQ: TOMZ), a global provider of disinfection and decontamination essentials through its premier Binary Io...

How does the current sentiment score (30) reflect market perception, and could it signal a buying or selling opportunity? Are there any upcoming catalyst events (e.g., product launches, partnership announcements, conference presentations) that could drive further price movement? What is the expected impact of the growth initiatives on the company's earnings per share (EPS) and revenue forecasts for the next 12‑24 months?

Symbol: TOMZ

26 days ago

Read more globenewswire